<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016122"><a href="http://purl.obolibrary.org/obo/MONDO_0016122">MONDO:0016122</a></h3>
<p><strong>Label:</strong> periodic paralysis (disease)</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0008223">MONDO:0008223</a> (hypokalemic periodic paralysis), <a href="http://purl.obolibrary.org/obo/MONDO_0019201">MONDO:0019201</a> (thyrotoxic periodic paralysis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_613345">OMIM:613345</a>, <a href="http://www.orpha.net/ORDO/Orphanet_681">Orphanet:681</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613239">OMIM:613239</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614834">OMIM:614834</a>, <a href="http://purl.obolibrary.org/obo/OMIM_188580">OMIM:188580</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79102">Orphanet:79102</a>, <a href="http://purl.obolibrary.org/obo/OMIM_170400">OMIM:170400</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) and <a href="http://purl.obolibrary.org/obo/HP_0012726">HP:0012726</a> (Episodic hypokalemia) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011998">HP:0011998</a> (Postprandial hyperglycemia) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011042">HP:0011042</a> (Abnormality of potassium homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011021">HP:0011021</a> (Abnormality of circulating enzyme level) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011015">HP:0011015</a> (Abnormality of blood glucose concentration) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011014">HP:0011014</a> (Abnormal glucose homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011013">HP:0011013</a> (Abnormality of carbohydrate metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010930">HP:0010930</a> (Abnormality of monovalent inorganic cation homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010929">HP:0010929</a> (Abnormality of cation homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010876">HP:0010876</a> (Abnormality of circulating protein level) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010547">HP:0010547</a> (Muscle flaccidity) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009020">HP:0009020</a> (Exercise-induced muscle fatigue) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008180">HP:0008180</a> (Mildly elevated creatine phosphokinase) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008153">HP:0008153</a> (Periodic hypokalemic paresis) and <a href="http://purl.obolibrary.org/obo/HP_0012240">HP:0012240</a> (Increased intramyocellular lipid droplets) 64.29%</li>
</ul>
</body>
</html>
